SEC Filing Analysis: Strata Critical Medical, Inc. (SRTA)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Accounting Officer received vested performance-based stock units (PSUs) and subsequently disposed of a portion of those shares to cover tax liabilities, a common and non-discretionary event.
• Market Impact: Neutral. This is a routine compensation-related transaction with negligible impact on the market.

Company Information

Field	Value
Company	Strata Critical Medical, Inc.
Ticker Symbol	SRTA
CIK	0001779128
Industry	Health Services

Insider Information

Field	Value
Name	Cohen Amir
CIK	0001861140
Title/Position	Chief Accounting Officer
Relationship	Officer

Transaction Details

This filing reports two transactions: the vesting of an award and a subsequent disposition to cover taxes.

Transaction 1: Award Vesting

Field	Value
Form Type	4
Transaction Date	2025-10-31
Transaction Code	A (Award)
Security Type	Class A common stock, $0.0001 par value per share
Shares Involved	41,786
Price Per Share	$0.00
Total Value	$0 (Market value ~$210,184)
Ownership Type	Direct

Transaction 2: Tax Withholding

Field	Value
Form Type	4
Transaction Date	2025-11-03
Transaction Code	F (Payment of tax liability by withholding security)
Security Type	Class A common stock, $0.0001 par value per share
Shares Involved	20,497
Price Per Share	$5.03
Total Value	$103,100
Ownership Type	Direct

Final shares owned after both transactions: 121,342

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value (Award Market Value)	~$210,184
% of Market Cap	0.053%
Shares Transacted (Award)	41,786
% of Shares Outstanding	0.051%
Post-Transaction Ownership	121,342 shares (0.15% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: Strata Critical Medical has a market capitalization of approximately $400 million. The market value of the vested award is about 0.05% of the company's market cap, which is not material.
• Ownership Concentration: The insider's post-transaction holding of 121,342 shares represents a minimal 0.15% of total shares outstanding, indicating low ownership concentration.
• Dilution Impact: The net issuance of 21,289 shares (41,786 award - 20,497 tax sale) represents a negligible 0.026% of shares outstanding, posing no meaningful dilution risk to existing shareholders from this event.
• Transaction Significance: The transaction is classified as low significance. It is a pre-planned compensation event, and the associated sale is non-discretionary ('sell-to-cover'), providing no insight into the insider's sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The filing details a routine vesting of performance shares and an automatic tax withholding sale. These events are expected as part of executive compensation and carry no new information or signal to the market.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is not an open-market trade and is too small to impact trading volume.
• Sentiment Indicator: Neutral. This is a standard procedural filing, not a discretionary investment decision.

Additional Context

Transaction Notes

• Footnote 1: Confirms the acquisition of 41,786 shares resulted from the vesting of Performance-Based Restricted Stock Units (PSUs) granted on March 8, 2024.
• Footnote 2: Confirms the disposition of 20,497 shares was to satisfy tax withholding obligations related to the PSU vesting. This is not a discretionary sale.